4.7 Article

Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 63, Issue 11, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01184-19

Keywords

invasive fungal infections; antifungal therapy; plasma drug levels; therapeutic drug monitoring; Rhinocladiella mackenziei; cerebral phaeohyphomycosis

Ask authors/readers for more resources

Posaconazole diffusion has been documented in various organs, which contrasts with the scarce data available for the human central nervous system (CNS). We analyzed posaconazole concentrations in plasma and multiple CNS specimens taken from a patient who received posaconazole because of cerebral phaeohyphomycosis. Low posaconazole concentrations were obtained in CNS specimens, with sample-to-plasma ratios between 5% and 22%. This case highlights the role of neurosurgery during cerebral phaeohyphomycoses, even those caused by posaconazole-susceptible black fungi.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available